Discovery Laboratories, Inc. (NASDAQ:DSCO)

CAPS Rating: 3 out of 5

A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases.

Recs

2
Player Avatar calisurfer19 (47.28) Submitted: 6/29/2011 7:30:55 AM : Outperform Start Price: $2.17 DSCO Score: -78.00

Riding out the storm till patent is approved or not.

Featured Broker Partners


Advertisement